2001
DOI: 10.1053/jcan.2001.23282
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of the effects of a cell saver and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0
1

Year Published

2003
2003
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(11 citation statements)
references
References 34 publications
0
10
0
1
Order By: Relevance
“…Two other studies reported that employment of cell saver was not associated with any adverse impact on coagulation parameters or increased blood product transfusion rates. 33,34 However, the extensive use of cell salvage systems to process cardiotomy blood may lead to a critical loss of coagulation factors and platelets, resulting in a bleeding diathesis. 35 The findings of our study are in agreement with the latter statement.…”
Section: Djaiani Et Al Cognitive Decline and Coronary Bypass Surgerymentioning
confidence: 99%
“…Two other studies reported that employment of cell saver was not associated with any adverse impact on coagulation parameters or increased blood product transfusion rates. 33,34 However, the extensive use of cell salvage systems to process cardiotomy blood may lead to a critical loss of coagulation factors and platelets, resulting in a bleeding diathesis. 35 The findings of our study are in agreement with the latter statement.…”
Section: Djaiani Et Al Cognitive Decline and Coronary Bypass Surgerymentioning
confidence: 99%
“…16 Although studies in adults indicate that this agent can decrease blood loss and transfusion requirements in spinal operations, none of these studies used a randomized, blinded study design to assess the efficacy of aprotinin. [17][18][19] We used this type of study design to evaluate the effectiveness of aprotinin in pediatric patients who were undergoing a long segment posterior spinal fusion. …”
mentioning
confidence: 99%
“…Autologous blood cell salvage is used routinely in many parts of the world in cardiac [ASA Task Force on Perioperative Blood Transfusion and Adjuvant Therapies 2006] and other high-risk operations [Goodnough 2003]. We studied 3 reviews [Goodnough 2003; ASA Task Force on Perioperative Blood Transfusion and Adjuvant Therapies 2006; Ferraris 2007] and 17 clinical trials [Moran 1978;Thurer 1979;Cordell 1981;Winton 1982;Keeling 1983;Mayer 1985;Dietrich 1989;Hall 1990;Merville 1991;Despotis 1996;Tempe 1996;Lee 1997;Gray 2001;Tempe 2001;Daane 2003;Svenmarker 2003; (Table 3). Most of the trials are RCTs [Moran 1978;Thurer 1979;Mayer 1985;Dietrich 1989;Merville 1991;Tempe 1996;Tempe 2001;Daane 2003;Svenmarker 2003;.…”
Section: Red Cell Savingmentioning
confidence: 99%
“…Today, cell saving devices can process quickly even small amounts of blood, require small priming volumes, continuously return high quality blood during and after surgery, and can collect blood not only during heparinization, but also when there is no heparin effect (eg, during internal mammary artery preparation). Several reports document the safety of the cell saver and support its routine use in cardiac surgery as a means to reduce blood transfusion [Moran 1978;Cordell 1981;Winton 1982;Keeling 1983;Mayer 1985;Hall 1990;Lee 1997;Tempe 2001], and intraoperative autologous blood donation combined with cell saver use decreases transfusion requirements in small-size patients (mean body weight of 45 kg) [Tempe 1996]. In a recent RCT, patients scheduled for CABG were randomized to autotransfusion (receiving autotransfused washed blood from intraoperative cell salvage and postoperative mediastinal fl uid cell salvage, n = 98), or control (receiving stored homologous blood only, n = 102).…”
Section: Red Cell Savingmentioning
confidence: 99%